MIR3135B Gene

HGNC Family Non-coding RNAs
Name microRNA 3135b
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMicroRNAs are emerging as key regulators in various cardiometabolic disorders, serving as both functional modulators and biomarkers. In a study focused on gestational diabetes mellitus, researchers explored the potential role of miRNAs in regulating serum lipids and blood glucose levels."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " Although the work on gestational diabetes did not single‐out a specific miRNA, it underscored the broader importance of miRNAs in metabolic regulation—a context within which MIR3135B may be implicated.\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn contrast, the investigation into severe hypertension directly identified MIR3135B as a differentially expressed circulating miRNA. Patients with severe hypertension exhibited distinct expression levels of MIR3135B relative to healthy controls, suggesting that MIR3135B could serve as a potential biomarker for the condition. Moreover, the differential regulation of its independent target genes hints at a functional role in the pathophysiology of hypertension."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nTogether, these studies propose that while the precise mechanistic contribution of MIR3135B to metabolic processes remains to be fully elucidated, its altered expression in severe hypertension highlights a promising potential for diagnostic or prognostic utility. The integration of these findings emphasizes a broader theme: specific miRNAs such as MIR3135B may have distinct regulatory roles depending on the pathological context, ranging from subtle effects in metabolic regulation to a clear marker in cardiovascular dysregulation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Fuyan Wang, Zhulin Li, Ming Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating miRNAs miR-574-5p and miR-3135b are potential metabolic regulators for serum lipids and blood glucose in gestational diabetes mellitus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gynecol Endocrinol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/09513590.2021.1908990"}], "href": "https://doi.org/10.1080/09513590.2021.1908990"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34126831"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34126831"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Jikang Shi, Yaxuan Ren, Yunkai Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating miR-3135b and miR-107 are potential biomarkers for severe hypertension."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hum Hypertens (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41371-020-0338-0"}], "href": "https://doi.org/10.1038/s41371-020-0338-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32327699"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32327699"}]}]}]}
NCBI Gene ID 100616218
API
Download Associations
Predicted Functions View MIR3135B's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR3135B's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR3135B's ARCHS4 Predicted Functions.

Functional Associations

MIR3135B has 133 functional associations with biological entities spanning 2 categories (disease, phenotype or trait, cell line, cell type or tissue) extracted from 3 datasets.

Click the + buttons to view associations for MIR3135B from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
GWASdb SNP-Disease Associations diseases associated with MIR3135B gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.
GWASdb SNP-Phenotype Associations phenotypes associated with MIR3135B gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR3135B gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.